glp-1 lawsuit news today 2025 Mounjaro - July 2026 Update GLP-1 NAION Vision Loss Lawsuit

100% with 30% reduction), normalization of ALT in 79% of those who had it elevated, and improvements in non-invasive markers of fibrosis 22

Expiration Date

This rebound illustrates the persistent challenge of sustaining weight loss without continued treatment, suggesting long-term medication use may be essential to maintaining results

Everything is heading in the right direction, and then having to switch can be very disruptive. When Dushay is looking through a patients medical chart, she says, her stomach churns when she sees the little box that indicates their insurance information

Exploring the relationship between Efpeglenatide dose and cardiovascular outcomes in type 2 diabetes: insights from the AMPLITUDE-O trial

Martchenko A, Oh RH, Wheeler SE, Gurges P, Chalmers JA, Brubaker PL